Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

A Paper-Based Test for Screening Newborns for Sickle Cell Disease.

Piety NZ, George A, Serrano S, Lanzi MR, Patel PR, Noli MP, Kahan S, Nirenberg D, Camanda JF, Airewele G, Shevkoplyas SS.

Sci Rep. 2017 Apr 3;7:45488. doi: 10.1038/srep45488.

2.

A framework for assessing outcomes from newborn screening: on the road to measuring its promise.

Hinton CF, Homer CJ, Thompson AA, Williams A, Hassell KL, Feuchtbaum L, Berry SA, Comeau AM, Therrell BL, Brower A, Harris KB, Brown C, Monaco J, Ostrander RJ, Zuckerman AE, Kaye C, Dougherty D, Greene C, Green NS; Follow-up and Treatment Sub-committee of the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC).

Mol Genet Metab. 2016 Aug;118(4):221-9. doi: 10.1016/j.ymgme.2016.05.017. Epub 2016 May 31.

PMID:
27268406
3.

Novel insights in the management of sickle cell disease in childhood.

Iughetti L, Bigi E, Venturelli D.

World J Clin Pediatr. 2016 Feb 8;5(1):25-34. doi: 10.5409/wjcp.v5.i1.25. eCollection 2016 Feb 8. Review.

4.

Emergency medical genomes: a breakthrough application of precision medicine.

Kingsmore SF, Petrikin J, Willig LK, Guest E.

Genome Med. 2015 Jul 30;7(1):82. doi: 10.1186/s13073-015-0201-z. eCollection 2015.

5.

Sickle cell disease in areas of immigration of high-risk populations: a low cost and reproducible method of screening in northern Italy.

Venturelli D, Lodi M, Palazzi G, Bergonzini G, Doretto G, Zini A, Monica C, Cano MC, Ilaria M, Montagnani G, Paolucci P.

Blood Transfus. 2014 Jul;12(3):346-51. doi: 10.2450/2013.0188-13. Epub 2014 Mar 19.

6.

Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings.

Hinton CF, Mai CT, Nabukera SK, Botto LD, Feuchtbaum L, Romitti PA, Wang Y, Piper KN, Olney RS.

Genet Med. 2014 Jun;16(6):484-90. doi: 10.1038/gim.2013.177. Epub 2013 Dec 5.

7.

Remote monitoring of pain and symptoms using wireless technology in children and adolescents with sickle cell disease.

Jacob E, Duran J, Stinson J, Lewis MA, Zeltzer L.

J Am Assoc Nurse Pract. 2013 Jan;25(1):42-54. doi: 10.1111/j.1745-7599.2012.00754.x. Epub 2012 Jul 12.

8.

Screening criteria: the need to deal with new developments and ethical issues in newborn metabolic screening.

Forman J, Coyle F, Levy-Fisch J, Roberts P, Terry S, Legge M.

J Community Genet. 2013 Jan;4(1):59-67. doi: 10.1007/s12687-012-0118-9. Epub 2012 Oct 7.

9.

Tracking clinical genetic services for newborns identified through newborn dried bloodspot screening in the United States-lessons learned.

Livingston J, Therrell BL Jr, Mann MY, Anderson CS, Christensen K, Gorski JL, Grange DK, Peck D, Roberston M, Rogers S, Taylor M, Kaye CI.

J Community Genet. 2011 Dec;2(4):191-200. doi: 10.1007/s12687-011-0055-z. Epub 2011 Jul 6.

10.

Genetic screening.

Burke W, Tarini B, Press NA, Evans JP.

Epidemiol Rev. 2011;33:148-64. doi: 10.1093/epirev/mxr008. Epub 2011 Jun 27. Review.

11.

Reproductive decisions in people with sickle cell disease or sickle cell trait.

Gallo AM, Wilkie D, Suarez M, Labotka R, Molokie R, Thompson A, Hershberger P, Johnson B.

West J Nurs Res. 2010 Dec;32(8):1073-90. doi: 10.1177/0193945910371482. Epub 2010 Aug 11.

12.

Newborn screening in Canada - Are we out of step?

Hanley WB.

Paediatr Child Health. 2005 Apr;10(4):203-7.

Supplemental Content

Support Center